Interventional neurology is an emerging subspecialty within neurology that utilizes minimally invasive endovascular techniques and image guidance to diagnose and treat various neurological disorders. These include conditions affecting the brain, spinal cord and nerves. Over the past decade, there has been a paradigm shift from open surgery to less invasive image-guided procedures for many neurological conditions. Interventional neurologists perform diagnostic cerebral angiography to evaluate the arteries of the brain and neck. They also conduct a variety of minimally invasive procedures such as mechanical thrombectomy to remove potentially deadly blood clots causing strokes, embolization of brain arteriovenous malformations (AVMs) and aneurysms, placement of flow diversion stents to treat complex aneurysms, angioplasty and stent placement for vertebral artery and intracranial artery stenosis, as well as pain management procedures.
Rise of Mechanical Thrombectomy
One area that has seen remarkable progress is the treatment of acute ischemic stroke caused by a large vessel occlusion in the brain. After decades of limited treatment options involving clot-busting drugs alone, mechanical thrombectomy has revolutionized stroke care and improved patient outcomes. Multiple randomized clinical trials since 2015 have demonstrated the benefits of fast transfer to comprehensive stroke centers and early mechanical clot retrieval, in addition to clot-busting drugs. This has led to updated guidelines recommending thrombectomy as standard of care for select stroke patients within 24 hours of onset of symptoms. With improved patient selection, novel stroke devices and operator experience, reperfusion and functional independence rates continue to improve for stroke patients treated with minimally invasive thrombectomy approaches.
Evolving Non-surgical Options for Brain Aneurysms
Another major application of endovascular techniques in neurology involves the treatment of brain aneurysms, weak bulges in the wall of cerebral arteries that can bleed and cause strokes. Previously, neurosurgery was the only option for managing ruptured or high-risk unruptured aneurysms. With the development of advanced endovascular coiling and flow diversion technologies, over 80% of brain aneurysms are now treated using minimally invasive approaches through the arteries of the leg rather than open skull base surgery. Placement of detachable platinum coils into aneurysms to occlude their inward projection or novel flow diverting stents to reconstruct defective arteries have significantly reduced aneurysm treatment risks and enabled safe management of complex wide-neck aneurysms previously considered untreatable. Long-term durability of these endovascular techniques continues to be investigated versus neurosurgical clipping.
Advancing Interventions for Spinal Problems
In the spine, interventional radiologists often partner with neurosurgeons and neurologists to minimally invasively treat conditions causing back and leg pain. These include decompression of narrowed spinal canals through procedures such as vertebroplasty to treat vertebral compression fractures and kyphoplasty to reconstruct collapsed vertebrae. Interventional approaches are also being evaluated to treat radiculopathy from herniated discs, canal stenosis and facet joint pain. Emerging technologies involve minimally invasive placement of intradiscal prostheses, spinal cord and nerve root stimulators, as well as vertebral augmentation using biomaterials instead of cement. Overall, these advancements aim to provide pain relief with less risk of long-term immobilization compared to traditional spine surgery.
Growing Role in Neuro-Oncology
Image-guided tumor ablation using radiofrequency, microwave or cryoenergy is also increasingly used by neurointerventionalists to palliatively treat certain primary and metastatic brain tumors deemed inoperable. These minimally invasive procedures help alleviate tumor symptoms and potentially prolong survival in select patients. Interventional techniques also assist in precise tumor biopsy sampling under imaging guidance for histological diagnosis that may obviate the need for open surgery in some cases. Emerging options involve convection-enhanced delivery of chemotherapy wafers directly into brain tumors as well as placement of catheters for intra-arterial chemotherapy infusion. The evolving field of neuro-oncology continues to explore minimally invasive approaches either independently or in combination with other treatments.
Future Growth Areas
Though still in its infancy, interventional neurology represents an innovative field with huge potential for continued growth by translating neuroendovascular techniques from research to standard clinical practice. Areas primed for further progress include acute stroke systems of care, complex aneurysm and AVM treatment, intrathecal therapies for hydrocephalus and pain management, as well as spinal and neuro-oncology interventions. Implementation of artificial intelligence and robotics may augment endovascular procedures. Wider geographic access to high quality image guided neurointerventions could significantly impact public health by improving outcomes for millions affected by neurovascular disorders worldwide annually. With further innovations and supportive healthcare policies, interventional neurology is positioned to revolutionize care over the next decade for some of the most challenging diseases afflicting the nervous system.
Market HighlightsThe Global interventional neurology market is expected to grow at an approximate CAGR of 7.8% during forecast period, 2018–2023.Increasing participation of market players is the key factor driving the interventional neurology market.
For instance, in 2018, Rapid Medical announced CE Mark approval in the European Union for its Tigertriever 13 stent retriever for the treatment of ischemic stroke.Various other factors such as technological advancements, presence of a large target patient population, favourable medical reimbursements and growing demand for effective neurovascular devices are also expected to propel the growth of the market.However, lack of skilled neurosurgeons and stringent regulations can hinder the market growth over the forecast period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7211Regional AnalysisThe Americas dominated the global market for interventional neurology owing to presence of major market players and rising geriatric population.In 2017, it was estimated that Europe stood second in the global interventional neurology market.
Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region.On the other hand, the Middle East and Africa held least share in the global interventional neurology market due to the low per capita income, especially within the African region.
The burden of neurological disorders in African region has been increasing over the years.
The annual incidence of stroke has been estimated to be 316 per 100 000 in Africa.SegmentationThe Global interventional neurology market is segmented based on disease pathology, product, end user and region.The Global market for interventional neurology, by disease pathology is segmented into cerebral aneurysms, arteriovenous malformation and fistulas, ischemic strokes, and others.The market, by product, is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty and stenting systems, neurothrombectomy devices, and support devices.The aneurysm coiling & embolization devices segment is further classified as embolic coils, flow diversion devices, and liquid embolic agents.
The cerebral balloon angioplasty and stenting systems segment is further classified as carotid artery stents, and embolic protection systems.
Interventional Neurology Market Research Report: By Disease Pathology (Cerebral Aneurysms, Ischemic Strokes, & Others), Product (Aneurysm Coiling & Embolization, Neurothrombectomy, Support Devices, & Others), End User – Global Forecast Till 2027Market HighlightsThe Global interventional neurology market is expected to grow at an approximate CAGR of 7.8% during forecast period, 2018–2023.Increasing participation of market players is the key factor driving the interventional neurology market.
For instance, in 2018, Rapid Medical announced CE Mark approval in the European Union for its Tigertriever 13 stent retriever for the treatment of ischemic stroke.Various other factors such as technological advancements, presence of a large target patient population, favourable medical reimbursements and growing demand for effective neurovascular devices are also expected to propel the growth of the market.However, lack of skilled neurosurgeons and stringent regulations can hinder the market growth over the forecast period.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7211SegmentationThe Global interventional neurology market is segmented based on disease pathology, product, end user and region.The Global market for interventional neurology, by disease pathology is segmented into cerebral aneurysms, arteriovenous malformation and fistulas, ischemic strokes, and others.The market, by product, is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty and stenting systems, neurothrombectomy devices, and support devices.
The cerebral balloon angioplasty and stenting systems segment is further classified as carotid artery stents, and embolic protection systems.
The neurothrombectomy devices are further classified as clot retrieval devices, suction and aspiration devices, and snares.
The support devices are further classified as microcatheters, and microguidewires.Based on end user, the market is segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/interventional-neurology-market-7211 Regional AnalysisThe Americas dominated the global market for interventional neurology owing to presence of major market players and rising geriatric population.In 2017, it was estimated that Europe stood second in the global interventional neurology market.
Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region.On the other hand, the Middle East and Africa held least share in the global interventional neurology market due to the low per capita income, especially within the African region.
